Magpie MedTech Ventures

Overview

Magpie MedTech Ventures is a specialized fund that offers pre-seed capital and domain expertise to medical device and digital health startups. The fund is led by principals with proven records and exceptional expertise in healthcare, commercialization, and startup investment. Their deep networks and domain expertise in regulated venture creation, along with a unique partnership with the New England Medical Innovation Center (NEMIC), make Magpie MedTech Ventures a top choice for entrepreneurs seeking funding and support. The fund focuses on high-impact MedTech ventures, providing domain expertise and value-based mentoring. They offer pre-seed funding consisting of cash investments and in-kind services up to $150,000, with flexible deal terms. Their team comprises physicians with deep clinical expertise, corporate executives, serial entrepreneurs with successful exits, and investors, all committed to facilitating insights into healthcare providers' needs, market and user adoption, access to commercial partners, key opinion leaders, and investors. Magpie MedTech Ventures operates an accelerator program that includes product development and gap analysis, curated capital management plans, milestone-based project plans, leadership training, and connections to an extensive network of project managers, subject matter experts, key opinion leaders, and advisors. The program has an intense 3-month duration, with applications accepted on a rolling basis. Post-program, startups are invited to participate in NEMIC-facilitated pitch events and are facilitated introductions to a network of angel investment groups and micro-VCs. The fund emphasizes building and maintaining long-term relationships to ensure alumni achieve success, including board engagement, networking events, and extended mentoring services.

Investment Focus

• Pre-Seed and post-ideation product development stage startup
• Clear value proposition with both clinical/system and market value
• Strong defensibility and competitive differentiation
• Technology under CDRH regulations with a pathway to regulation
• Magpie & NEMIC managers have clear, demonstrable value to the startup
• Clear pathway to raising future funding rounds